Your browser doesn't support javascript.
loading
Regulations, liability, safety, and economics related to compounding.
Campbell, Elliott H; Elston, Dirk M; Straughan, Chad L; Antonovich, Diana D.
Affiliation
  • Campbell EH; Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: elliott.campbell@uky.edu.
  • Elston DM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.
  • Straughan CL; Tidewater Pharmacy & Medical Supply, Charleston, South Carolina.
  • Antonovich DD; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.
J Am Acad Dermatol ; 83(1): 184-188, 2020 Jul.
Article in En | MEDLINE | ID: mdl-31821858
ABSTRACT
Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Compounding Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Compounding Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article